BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 35300518)

  • 1. Biopharmaceutical Manufacturing: Historical Perspectives and Future Directions.
    Szkodny AC; Lee KH
    Annu Rev Chem Biomol Eng; 2022 Jun; 13():141-165. PubMed ID: 35300518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Throughput Optimization of Continuous Biopharmaceutical Manufacturing Facilities.
    Garcia FA; Vandiver MW
    PDA J Pharm Sci Technol; 2017; 71(3):189-205. PubMed ID: 27974629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward microfluidic continuous-flow and intelligent downstream processing of biopharmaceuticals.
    Sharma V; Mottafegh A; Joo JU; Kang JH; Wang L; Kim DP
    Lab Chip; 2024 May; 24(11):2861-2882. PubMed ID: 38751338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developments and opportunities in continuous biopharmaceutical manufacturing.
    Khanal O; Lenhoff AM
    MAbs; 2021; 13(1):1903664. PubMed ID: 33843449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Current Scientific and Regulatory Landscape in Advancing Integrated Continuous Biopharmaceutical Manufacturing.
    Fisher AC; Kamga MH; Agarabi C; Brorson K; Lee SL; Yoon S
    Trends Biotechnol; 2019 Mar; 37(3):253-267. PubMed ID: 30241924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling the Downstream Processing of Monoclonal Antibodies Reveals Cost Advantages for Continuous Methods for a Broad Range of Manufacturing Scales.
    Hummel J; Pagkaliwangan M; Gjoka X; Davidovits T; Stock R; Ransohoff T; Gantier R; Schofield M
    Biotechnol J; 2019 Feb; 14(2):e1700665. PubMed ID: 29341493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applications of Raman Spectroscopy in Biopharmaceutical Manufacturing: A Short Review.
    Buckley K; Ryder AG
    Appl Spectrosc; 2017 Jun; 71(6):1085-1116. PubMed ID: 28534676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clarification technologies for monoclonal antibody manufacturing processes: Current state and future perspectives.
    Singh N; Arunkumar A; Chollangi S; Tan ZG; Borys M; Li ZJ
    Biotechnol Bioeng; 2016 Apr; 113(4):698-716. PubMed ID: 26302443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recommendations for Enhancing Quality and Capability of Indian Biopharmaceutical Industry: Summary of a Workshop.
    Uppal A; Koduri CK; Yadlapalli S; Chirmule N; Chakrabarti R; Atouf F
    J Pharm Sci; 2020 Oct; 109(10):2958-2961. PubMed ID: 32710904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Industrialization of mAb production technology: the bioprocessing industry at a crossroads.
    Kelley B
    MAbs; 2009; 1(5):443-52. PubMed ID: 20065641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of difficult-to-remove host cell protein impurities during extended Chinese hamster ovary cell culture and their impact on continuous bioprocessing.
    Valente KN; Lenhoff AM; Lee KH
    Biotechnol Bioeng; 2015 Jun; 112(6):1232-42. PubMed ID: 25502542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Research and Development of Manufacturing of Biologics-the Activities of Manufacturing Association of Biologics].
    Omasa T
    Yakugaku Zasshi; 2022; 142(7):723-729. PubMed ID: 35781501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent applications of quantitative mass spectrometry in biopharmaceutical process development and manufacturing.
    Li X
    J Pharm Biomed Anal; 2023 Sep; 234():115581. PubMed ID: 37494866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. License Compliance Issues For Biopharmaceuticals: Special Challenges For Negotiations Between Companies And Non-Profit Research Institutions.
    Ponzio TA; Feindt H; Ferguson S
    LES Nouv; 2011 Sep; 46(3):216-225. PubMed ID: 22162900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Driving adoption of new technologies in biopharmaceutical manufacturing.
    Schaefer G; Balchunas J; Charlebois T; Erickson J; Hart R; Kedia SB; Lee KH
    Biotechnol Bioeng; 2023 Sep; 120(9):2765-2770. PubMed ID: 37053004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous integrated manufacturing for biopharmaceuticals: A new paradigm or an empty promise?
    Rathore AS; Thakur G; Kateja N
    Biotechnol Bioeng; 2023 Feb; 120(2):333-351. PubMed ID: 36111450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innovative Drying Technologies for Biopharmaceuticals.
    Sharma A; Khamar D; Cullen S; Hayden A; Hughes H
    Int J Pharm; 2021 Nov; 609():121115. PubMed ID: 34547393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of Raman spectroscopy in biopharmaceuticals from development to manufacturing.
    Esmonde-White KA; Cuellar M; Lewis IR
    Anal Bioanal Chem; 2022 Jan; 414(2):969-991. PubMed ID: 34668998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved Titer in Late-Stage Mammalian Cell Culture Manufacturing by Re-Cloning.
    He Q; Rehmann MS; Tian J; Xu J; Sabino L; Vandermark E; Basson Z; Po I; Bierilo K; Tremml G; Rizzi G; Langsdorf EF; Qian NX; Borys MC; Khetan A; Li ZJ
    Bioengineering (Basel); 2022 Apr; 9(4):. PubMed ID: 35447733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Market of Biopharmaceutical Medicines: A Snapshot of a Diverse Industrial Landscape.
    Moorkens E; Meuwissen N; Huys I; Declerck P; Vulto AG; Simoens S
    Front Pharmacol; 2017; 8():314. PubMed ID: 28642701
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.